Recombinant multi-species TENT4A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TENT4A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a DNA polymerase that is likely involved in DNA repair. In addition, the encoded protein may be required for sister chromatid adhesion. Alternatively spliced transcript variants that encode different isoforms have been described. [provided by RefSeq, Jan 2010]
The Alternative Names of target: DNA polymerase sigma,LAK-1,LAK1,Non-canonical poly(A) RNA polymerase PAPD7,PAP-associated domain-containing protein 7,PAPD7,POLK,POLS,Papd7,Pols,TENT4A,TRAMP-like complex polyadenylate polymerase,TRF4,TRF4-1,TRF41,TUTASE5,Tent4a,Terminal guanylyltransferase,Terminal nucleotidyltransferase 4A,Terminal uridylyltransferase 5 (TUTase 5),Topoisomerase-related function protein 4-1 (TRF4-1)
Go
to TENT4A products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP1320-Ag-1/ GM-Tg-hg-IP1320-Ag-2 | Human TENT4A protein | Human |
GM-Tg-rg-IP1320-Ag-1/ GM-Tg-rg-IP1320-Ag-2 | Rat TENT4A protein | Rat |
GM-Tg-mg-IP1320-Ag-1/ GM-Tg-mg-IP1320-Ag-2 | Mouse TENT4A protein | Mouse |
GM-Tg-cynog-IP1320-Ag-1/ GM-Tg-cynog-IP1320-Ag-2 | Cynomolgus/Rhesus macaque TENT4A protein | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP1320-Ag-1/ GM-Tg-felg-IP1320-Ag-2 | Feline TENT4A protein | Feline |
GM-Tg-cang-IP1320-Ag-1/ GM-Tg-cang-IP1320-Ag-2 | Canine TENT4A protein | Canine |
GM-Tg-bovg-IP1320-Ag-1/ GM-Tg-bovg-IP1320-Ag-2 | Bovine TENT4A protein | Bovine |
GM-Tg-equg-IP1320-Ag-1/ GM-Tg-equg-IP1320-Ag-2 | Equine TENT4A protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. |
GM-Tg-hg-IP1320-Ag-1/ GM-Tg-hg-IP1320-Ag-2;
GM-Tg-rg-IP1320-Ag-1/ GM-Tg-rg-IP1320-Ag-2;
GM-Tg-mg-IP1320-Ag-1/ GM-Tg-mg-IP1320-Ag-2; GM-Tg-cynog-IP1320-Ag-1/ GM-Tg-cynog-IP1320-Ag-2; GM-Tg-felg-IP1320-Ag-1/ GM-Tg-felg-IP1320-Ag-2; GM-Tg-cang-IP1320-Ag-1/ GM-Tg-cang-IP1320-Ag-2; GM-Tg-bovg-IP1320-Ag-1/ GM-Tg-bovg-IP1320-Ag-2; GM-Tg-equg-IP1320-Ag-1/ GM-Tg-equg-IP1320-Ag-2 |
Products Name | TENT4A protein |
Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
Target Name | TENT4A |
Protein Sub-location | Introcelluar Protein |
Isotypes | Recombinant protein |
Expression platform | Mammalian cell |
Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
Tag | His |
Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TENT4A protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab
GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.